Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine.
about
Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages.Mass spectrometry methodology in lipid analysis.The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin.Lysophosphatidic acid in atherosclerotic diseasesGroup VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acid.Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs.Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation.The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injuryElevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.Templated polymers enable selective capture and release of lysophosphatidic acid in human plasma via optimization of non-covalent binding to functional monomersComprehensive and quantitative analysis of lysophospholipid molecular species present in obese mouse liver by shotgun lipidomics.Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why?Simultaneous profiling of lysophospholipids and phospholipids from human plasma by nanoflow liquid chromatography-tandem mass spectrometry.Challenges in accurate quantitation of lysophosphatidic acids in human biofluidsQuantitation of phosphatidic acid and lysophosphatidic acid molecular species using hydrophilic interaction liquid chromatography coupled to electrospray ionization high resolution mass spectrometry.Development and application of a UHPLC-MS/MS metabolomics based comprehensive systemic and tissue-specific screening method for inflammatory, oxidative and nitrosative stress.
P2860
Q33607215-D48CD649-CAAF-428F-8026-F31F5B7941EEQ33907807-7B67C67A-A284-4D9C-AD6D-B30FD31A4029Q34080568-EF90F299-334C-41D3-A8AE-85EB7E0731EDQ34273486-7974EE96-CA7F-4E41-AAA6-09FE4218206CQ34378792-3191A72A-E1E4-4653-8AFA-D9DFA7B51BC2Q35061819-D26DCB1F-67DA-405A-9381-EE3B8BC324D1Q35325265-3C3E29B8-204B-4358-A1D4-4728800FA6C1Q35757561-1EE4AAAF-5D20-4EDB-B747-26F53B46A89DQ35889195-9B836162-7D92-477D-AB76-00E6D90220EBQ36117436-5D5D1BC0-8DAE-45A3-819C-D219B6F6862AQ36274382-47D9C1D6-A762-4920-8467-7CCD63BEC36BQ36315161-5D2884FE-4DCD-4911-84CF-465697D3C713Q37099149-5ACB6839-E18C-4511-BC33-9B0B19AA6AFDQ38474900-11EF87FB-0A15-44C6-9D57-46C723508D09Q42747131-9334A445-853D-4FEA-9E69-E8142867A4DDQ43629218-867154B3-1AD4-4131-B684-7D5860517C26Q55007448-1040E239-D3EF-4845-98E1-336D0973D1CE
P2860
Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Measurement of endogenous lyso ...... on of lysophosphatidylcholine.
@en
type
label
Measurement of endogenous lyso ...... on of lysophosphatidylcholine.
@en
prefLabel
Measurement of endogenous lyso ...... on of lysophosphatidylcholine.
@en
P2860
P1476
Measurement of endogenous lyso ...... on of lysophosphatidylcholine.
@en
P2093
P2860
P304
P356
10.1016/J.JCHROMB.2009.08.032
P577
2009-08-27T00:00:00Z